SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MARCONI, Peggy Carla Raffaella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.036
AS - Asia 6.189
EU - Europa 3.533
SA - Sud America 982
AF - Africa 139
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 4
Totale 22.896
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.769
SG - Singapore 2.280
CN - Cina 1.473
IT - Italia 806
BR - Brasile 745
VN - Vietnam 667
UA - Ucraina 543
HK - Hong Kong 517
GB - Regno Unito 462
DE - Germania 420
PL - Polonia 351
TR - Turchia 342
BD - Bangladesh 258
FR - Francia 224
FI - Finlandia 193
JP - Giappone 185
RU - Federazione Russa 147
CA - Canada 121
IN - India 114
MX - Messico 101
SE - Svezia 97
AR - Argentina 92
ID - Indonesia 88
NL - Olanda 78
ZA - Sudafrica 61
IQ - Iraq 46
ES - Italia 42
PK - Pakistan 40
CO - Colombia 39
BE - Belgio 30
EC - Ecuador 29
AT - Austria 28
UZ - Uzbekistan 27
LT - Lituania 22
VE - Venezuela 22
CL - Cile 20
MY - Malesia 19
SA - Arabia Saudita 19
MA - Marocco 18
PH - Filippine 17
PY - Paraguay 17
IE - Irlanda 16
AE - Emirati Arabi Uniti 15
CZ - Repubblica Ceca 14
AU - Australia 13
CH - Svizzera 12
JM - Giamaica 12
NP - Nepal 11
UY - Uruguay 10
ET - Etiopia 9
PA - Panama 9
CR - Costa Rica 8
AL - Albania 7
AZ - Azerbaigian 7
DZ - Algeria 7
EG - Egitto 7
IL - Israele 7
IR - Iran 7
KE - Kenya 7
PT - Portogallo 7
TN - Tunisia 7
JO - Giordania 6
GE - Georgia 5
HN - Honduras 5
KR - Corea 5
MD - Moldavia 5
NO - Norvegia 5
OM - Oman 5
BO - Bolivia 4
LB - Libano 4
RO - Romania 4
TH - Thailandia 4
KW - Kuwait 3
KZ - Kazakistan 3
MZ - Mozambico 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TW - Taiwan 3
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
CG - Congo 2
EE - Estonia 2
EU - Europa 2
GD - Grenada 2
GH - Ghana 2
GT - Guatemala 2
HR - Croazia 2
KG - Kirghizistan 2
MM - Myanmar 2
MN - Mongolia 2
NG - Nigeria 2
NI - Nicaragua 2
RE - Reunion 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TG - Togo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 22.875
Salva come PNG Salva come JPEG
Città #
Ashburn 1.521
Singapore 1.491
Fairfield 1.049
Woodbridge 1.034
San Jose 783
Houston 613
Jacksonville 560
Hong Kong 505
Chandler 498
Santa Clara 493
Beijing 474
Ann Arbor 437
Seattle 419
New York 374
Wilmington 363
Warsaw 338
Cambridge 337
Ferrara 221
Ho Chi Minh City 212
Dallas 202
Los Angeles 202
Izmir 188
Tokyo 172
Hanoi 166
Nanjing 149
Princeton 135
Lauterbourg 133
San Diego 108
Munich 104
São Paulo 88
Council Bluffs 82
Milan 77
Shanghai 67
Buffalo 65
Mexico City 61
Jakarta 59
Tianjin 55
Boardman 54
Bologna 54
Shenyang 53
Chicago 49
Orem 49
Montreal 45
Brooklyn 44
Helsinki 43
London 41
The Dalles 40
Turku 39
Hebei 37
Hefei 37
Poplar 35
Jiaxing 34
Rome 34
Chennai 33
Da Nang 33
Nanchang 32
Atlanta 31
Johannesburg 31
Frankfurt am Main 30
Brussels 29
Stockholm 29
Toronto 29
Changsha 28
Moscow 27
San Francisco 27
Phoenix 26
Boston 24
Manchester 23
Denver 22
Falls Church 22
Haiphong 22
Tashkent 22
Washington 20
Guangzhou 19
Norwalk 19
Rio de Janeiro 19
Vienna 19
Amsterdam 18
Falkenstein 18
Mountain View 18
Naples 18
Baghdad 17
Brasília 16
Dublin 16
Ningbo 16
Redwood City 16
New Delhi 15
San Mateo 15
Ankara 14
Dong Ket 14
Jinan 14
Kunming 14
Lahore 14
Nuremberg 14
Zhengzhou 14
Auburn Hills 13
Medellín 13
Orange 13
Belo Horizonte 12
Brno 12
Totale 15.483
Salva come PNG Salva come JPEG
Nome #
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors 327
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer 274
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 273
Antitumor effects of non-replicative herpes simplex vectors expressing antiangiogenic proteins and thymidine kinase on Lewis lung carcinoma establishment and growth. 270
CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis 266
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 264
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 260
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 244
Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. 242
Herpetic vectors inhibiting angiogenesis and inducing cell suicide in gliomas 238
Recombinant herpes simplex virus and uses therefor 229
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 226
Herpesvirus-based vectors for gene transfer, gene therapy and the development of novel vaccines 225
Control of Erwinia amylovora Growth by Moringa oleifera Leaf Extracts: In Vitro and in Planta Effects 218
HSV as a vector in vaccine development and gene therapy 217
Sustainable vs. Conventional Cleaning in Healthcare: Microbiological and Life Cycle Insights 211
Botulinum neurotoxin light chains expressed by defective herpes simplex virus type-1 vectors cleave snare proteins and inhibit cgrp release in rat sensory neurons 210
Herpesvirus-based vaccines 204
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity 201
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy 200
Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus 198
Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice 195
Capitolo 55 Retrovirus 194
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice 194
HSV as a vector in vaccine development and gene therapy 192
Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients 192
Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region 190
Development and application of replication-incompetent HSV-1-based vectors 189
Herpes Simplex Virus Growth, Preparation, and Assay 188
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 186
HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma 185
Temporal lobe epilepsy model, neural stem cells and gene therapy 185
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 185
Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1 184
Generation of a human induced pluripotent stem cell line (UNIFEi001-A) from a patient with Spinocerebellar ataxia type 1 (SCA1) 182
EFFECT OF TAT TRANSDOMINANT NEGATIVE MUTANTS ON HIV-1 REPLICATION IN JURKAT T-CELL LINES 181
Herpes simplex virus type 1 infects enteric neurons and triggers gut dysfunction via macrophage recruitment 180
Herpes simplex virus type 1 and Alzheimer’s disease: link and potential impact on treatment 180
null 179
Purinergic Signaling: A New Pharmacological Target Against Viruses? 179
Herpetic vectors inhibiting angiogenesis and Inducing cell suicide in gliomas 177
Engineering herpes simplex virus vectors for CNS applications 176
Ethosomal Gel for Topical Administration of Dimethyl Fumarate in the Treatment of HSV-1 Infections 174
Effects of Moringa oleifera Leaf Extracts on Xanthomonas campestris pv. campestris 174
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model 173
Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8(+) T cell tolerance in vivo 172
Comunicazione orale, KN: A New Vaccine Approach To Fight Mycobacterium Tuberculosis 170
Poster: Herpes simplex vaccine vector co-expressing fused Mycobacterium Tuberculosis immunogens and Tat adjuvant enhances cellular and humoral responses in Balb/c mice 169
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 168
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 167
Herpes simplex virus type 1 (HSV-1)-derived recombinant vectors for gene transfer and gene therapy 166
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 166
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 164
Gene transfer to muscle using herpes simplex virus-based vectors 163
Herpes Simplex Virus Type 1-Derived Recombinant and Amplicon Vectors 163
Construction of Replication Defective Herpes Simplex Virus Vectors. 163
Development of Replication-Defective Herpes Simplex Virus Vectors 163
Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications 162
An Evaluation of Hospital Cleaning Regimes—Microbiological Evaluation and LCA Analysis after Traditional and Sustainable/Green Procedures 161
Progress in development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis 160
Parenchymal cells critically curtail cytotoxic T-cell responses by inducing Bim-mediated apoptosis 160
Peripheral T Cells Re-Enter the Thymus and Interfere with Central Tolerance Induction 159
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide 158
Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity 158
Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach 158
Herpes Simplex Virus ICP27 Protein Inhibits AIM 2-Dependent Inflammasome Influencing Pro-Inflammatory Cytokines Release in Human Pigment Epithelial Cells (hTert-RPE 1) 157
Identification of replication-competent HSV-1 Cgal(+) strain targets in a mouse model of human hepatocarcinoma xenograft 157
Suppressing gain-of-function proteins via CRISPR/Cas9 system in SCA1 cells 157
Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis 156
Modulation of mucosal and systemic immunity by enteric administration of nonreplicating herpes simplex virus expressing cytokines 155
Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system 155
Analysis of Civil Environments Cleaning Services—Microbiological and LCA Analysis after Traditional and Sustainable Procedures 154
Capitolo 44 Herpesviridae 154
Connexin 43-enhanced suicide gene therapy using herpesviral vectors 153
Transcriptional targeting of B cells for induction of peripheral CD8 T cell tolerance 152
Lentiviral-mediated transcriptional targeting of dendritic cells for induction of T cell tolerance in vivo 152
MHC class I cross-presentation by dendritic cells counteracts viral immune evasion 151
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model 151
A Safe-by-Design Approach for the Synthesis of a Novel Cross-Linked Hyaluronic Acid with Improved Biological and Physical Properties 150
Cytokine gene delivery into the central nervous system using intrathecally injected nonreplicative viral vectors 150
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 147
Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model 146
Natural Polyphenol-Containing Gels against HSV-1 Infection: A Comparative Study 146
HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG35-55-induced experimental autoimmune encephalomyelitis in C57BL/6 mice 143
Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons 143
Mangiferin loaded smart gels for HSV-1 treatment 143
Magnolia officinalis L. bark extract and respiratory diseases: From traditional Chinese medicine to western medicine via network target 142
Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses 142
Comunicazione orale, Keynote speaker: Herpes Simplex Vector Expressing Hiv1 Tat: A New Strategy For Vaccine Development 142
Evaluating Cleaning Services in Civil Environments: Microbiological and Life Cycle Analysis Comparing Conventional and Sustainable Methods 141
Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors 141
HSV Recombinant Vectors for Gene Therapy 141
High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vector 136
Rapid method for construction of recombinant HSV gene transfer vectors 136
Replication-defective herpes simplex virus vectors for gene transfer in vivo 135
Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines 135
Gene transfer to muscle and spinal cord using herpes simplex virus-based vectors. 134
Implications of maturation for viral gene delivery to skeletal muscle 133
Chapter 8: Gene-transfer Tool: Herpes Simplex Virus Vectors 132
Highly differentiated T cells link systemic and vascular inflammation in a mouse model of recurrent psoriasis 131
Totale 17.774
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.885
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 15.716
Totale 119.601
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021100 0 0 0 0 0 0 0 0 0 0 0 100
2021/20221.383 48 182 75 63 53 48 94 80 61 103 134 442
2022/20231.200 147 29 63 136 159 181 47 140 172 21 73 32
2023/2024890 80 85 42 26 39 264 55 43 21 25 22 188
2024/20252.886 82 80 235 112 385 317 47 172 380 332 426 318
2025/20269.568 962 347 817 1.178 1.262 623 1.024 514 979 1.030 579 253
Totale 23.126